Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2/MasR/PPARγ/NR1D1/Gas1 axis
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvaf192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Qiujing Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Hauptthemen laut MEDLINE: Neointima, Vascular System Injuries, Myocytes, Smooth Muscle, Muscle, Smooth, Vascular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Vasostatin-2, a bioactive peptide derived from chromogranin A, has cardiovascular-protective and anti-inflammatory properties. However, its role in injury-induced vascular remodelling remains unclear. This study aimed to investigate whether serum vasostatin-2 levels are related to restenosis in patients following percutaneous coronary intervention (PCI), and whether this peptide influences vascular neointimal hyperplasia in a mouse model of femoral artery injury. Methods and results Serum vasostatin-2 levels were evaluated in patients with (n = 442) and without (n = 442) restenosis after PCI. Recombinant vasostatin-2 or saline was administered in a mouse model of femoral artery injury. A combination of multi-omics (Bulk RNA sequencing, CUT&Tag detection, and glutathione S-transferase pull-down/mass spectrometry analysis) was employed to investigate underlying mechanisms. Patients with restenosis had lower serum vasostatin-2 levels than those without restenosis (P < 0.001). Vasostatin-2 protein significantly inhibited neointimal hyperplasia and suppressed the vascular smooth muscle cell (VSMC) phenotype switch after injury. Mechanistically, vasostatin-2 was proven to bind angiotensin-converting enzyme 2 (ACE2) and activate the downstream nuclear receptor subfamily 1 group D member 1 (NR1D1)-growth arrest-specific 1 (Gas1) pathway, thereby facilitating apoptosis of VSMCs and inhibiting their proliferation. ACE2-binding incompetent vasostatin-2 mutants and NR1D1 deficiency in VSMCs weakened vasostatin-2 effect on neointimal hyperplasia in mice.
Conclusion
Decreased serum vasostatin-2 levels are associated with coronary artery restenosis in patients with coronary angioplasty. Vasostatin-2 attenuates vascular injury-induced neointimal growth in mice and inhibits the proliferation of VSMCs in vitro through the ACE2/NR1D1/Gas1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Institute of Cardiovascular Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Cardiology Division 1-Pisa University Hospital, University of Pisa, Pisa 56124, Italy.
- National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
ORCID-Profile: Lin Lu, Raffaele De Caterina
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, Q., Liu, J., Madonna, R., Li, F., Chen, S., Li, L., Wu, X., Maimati, Y., Ding, F., Wang, X., Shen, Y., Zhang, R., Shen, W., Dai, Y., Lu, L., & De Caterina, R. (2025). Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2/MasR/PPARγ/NR1D1/Gas1 axis. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf192
Vancouver
Chen Q, Liu J, Madonna R, Li F, Chen S, Li L, et al. Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2/MasR/PPARγ/NR1D1/Gas1 axis. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf192
BibTeX
@article{Chen2025,
author = {Chen, Qiujing and Liu, Jingmeng and Madonna, Rosalinda and Li, Feifei and Chen, Shuai and Li, Leying and Wu, Xinrui and Maimati, Yipaerguli and Ding, Fenghua and Wang, Xiaoqun and Shen, Ying and Zhang, Ruiyan and Shen, Weifeng and Dai, Yang and Lu, Lin and De Caterina, Raffaele},
title = {Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2/MasR/PPARγ/NR1D1/Gas1 axis},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvaf192}
}
EUVIMED